What is the current Takara Bio market capitalization?
The current market capitalization of Takara Bio is 125.11 B JPY.
Takara Bio Market capitalization 2024
Takara Bio Market capitalization
125.11 B JPY
Ticker
4974.T
ISIN
JP3460200003
WKN
A0DNGL
In 2024, Takara Bio's market cap stood at 125.11 B JPY, a -27.33% increase from the 172.17 B JPY market cap in the previous year.
The Takara Bio Market capitalization history
| YEAR | Market Capitalization (undefined JPY) |
|---|---|
| 2024 | 125.11 |
| 2023 | 186.42 |
| 2022 | 242.84 |
| 2021 | 351.78 |
| 2020 | 319.77 |
| 2019 | 275.99 |
| 2018 | 287.74 |
| 2017 | 184.12 |
| 2016 | 167.18 |
| 2015 | 158.06 |
| 2014 | 181.44 |
| 2013 | 238.09 |
| 2012 | 56.04 |
| 2011 | 53.04 |
| 2010 | 55.65 |
| 2009 | 58.9 |
| 2008 | 67.46 |
| 2007 | 106.62 |
| 2006 | 111.86 |
| 2005 | 111.28 |
Takara Bio Aktienanalyse
What does Takara Bio do?
Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Takara Bio's Market Capitalization
Takara Bio's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Takara Bio's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Takara Bio's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Takara Bio’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Takara Bio stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Takara Bio.
How has the market capitalization of Takara Bio developed in recent years?
The market capitalization of Takara Bio has increased/decreased by -27.33% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Takara Bio?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Takara Bio?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Takara Bio have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Takara Bio pay?
Over the past 12 months, Takara Bio paid a dividend of 17 JPY . This corresponds to a dividend yield of about 1.64 %. For the coming 12 months, Takara Bio is expected to pay a dividend of 19.79 JPY.
What is the dividend yield of Takara Bio?
The current dividend yield of Takara Bio is 1.64 %.
When does Takara Bio pay dividends?
Takara Bio pays a quarterly dividend. This is distributed in the months of April, April, April, April.
How secure is the dividend of Takara Bio?
Takara Bio paid dividends every year for the past 16 years.
What is the dividend of Takara Bio?
For the upcoming 12 months, dividends amounting to 19.79 JPY are expected. This corresponds to a dividend yield of 1.9 %.
In which sector is Takara Bio located?
Takara Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Takara Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Takara Bio from 6/1/2024 amounting to 17 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.
When did Takara Bio pay the last dividend?
The last dividend was paid out on 6/1/2024.
What was the dividend of Takara Bio in the year 2023?
In the year 2023, Takara Bio distributed 42 JPY as dividends.
In which currency does Takara Bio pay out the dividend?
The dividends of Takara Bio are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Takara Bio
Our stock analysis for Takara Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Takara Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
